Effects of Pioglitazone on Reverse Cholesterol Transport and HDL Function in Persons With Diabetes.

Trial Profile

Effects of Pioglitazone on Reverse Cholesterol Transport and HDL Function in Persons With Diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Dyslipidaemias; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Mar 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 13 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top